Results 11 to 13 of about 13 (13)

Improving practice in PD-L1 testing of non-small cell lung cancer in the UK: current problems and potential solutions. [PDF]

J Clin Pathol
Gosney JR, Peake MD, Kerr KM.
europepmc   +1 more source

Trends in NICE technology appraisals of non-small cell lung cancer drugs over the last decade. [PDF]

Eur J Health Econ
Westerink L, Wolters S, Zhou G, Postma A, Boersma C, van Boven JFM, Postma MJ.   +6 more
europepmc   +1 more source

Modelling Health State Utilities as a Transformation of Time to Death in Patients with Non-Small Cell Lung Cancer. [PDF]

Pharmacoeconomics
Hatswell AJ, Chaudhary MA, Monnickendam G, Moreno-Koehler A, Frampton K, Shaw JW, Penrod JR, Lawrance R.   +7 more
europepmc   +1 more source